Urgent Recall Issued for Popular Eczema Cream Due to Bacterial Contamination
A widely available eczema cream sold in stores and online across the United States is being urgently recalled after testing revealed contamination with a dangerous bacterium. Wisconsin-based Pharmacal has initiated a recall of its MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, which was sold at H-E-B grocery stores and on Amazon. The product has been found to contain Staphylococcus aureus, commonly known as staph.
Staph is a germ that resides on the skin of most individuals and in the nasal passages of approximately 30 percent of people. While typically harmless, it can sometimes lead to infections that range from mild to life-threatening. The U.S. Food and Drug Administration (FDA) issued a recall notice stating that use of the contaminated cream could result in a spectrum of infections, from localized issues to severe or fatal adverse events. Patients with weakened immune systems or compromised skin—such as those with wounds, burns, or skin disorders—are at heightened risk for serious infections, including skin and skin structure infections, infective endocarditis (infection of the heart valves), bone and joint infections, bloodstream infections, and life-threatening conditions like sepsis and septic shock.
The recalled product is specifically the brand's six-ounce tube with product code 5106 and UPC 012277051067. It bears an expiration date of November 2026. As of now, no adverse events have been reported in connection with this recall.
Pharmacal is notifying distributors and wholesalers and is working to facilitate the return of the recalled products. Consumers are urged to immediately discontinue use of the cream and dispose of it properly.
Understanding Eczema and the Recalled Product
Eczema is a chronic skin condition characterized by dry, itchy, and inflamed patches on the body. In severe cases, it can lead to bleeding and open sores. Approximately 32 million Americans are affected by eczema. The exact cause remains unknown but is believed to involve both genetic and environmental factors. Common triggers include cosmetics, hygiene products, stress, and allergens such as dander and pollen. Treatment typically involves moisturizing, topical steroids, and phototherapy.
The recalled MG217 product contains colloidal oatmeal—finely ground and boiled-down oats that act as a natural skin protectant, moisturizer, and anti-inflammatory agent. It is FDA-regulated and has been proven to soothe skin, including eczema-affected areas. The product claims to provide fast, long-lasting relief from itching, irritation, and dryness and is suitable for children and babies. It also states that it helps prevent symptom recurrence.
It remains unclear how the product became contaminated with staph. Staph infections are typically treatable with antibiotics; however, antibiotic-resistant strains of staph are becoming more common, raising concerns about more severe infections that could lead to serious or fatal complications.
